Come up with a name for your new list and we'll add to it:
RedPath Integrated Pathology raised a round of funding on July 13, 2006. Investors include
Pittsburgh Life Sciences Greenhouse.
RedPath Integrated Pathology is a genomics-based molecular diagnostics company that provides cancer diagnostic testing for pathologists, oncologists and clinicians. The company's CLIA licensed, CAP ce…